Despite lung cancer being one of the most prevalent cancers in India, accounting for 10% of total cancer deaths, there exists a significant gap in evidence-based protocols for its prevention, screening, diagnosis, management, and palliation.
Recognizing this critical gap, the ICMR has initiated an expression of interest (EoI) from researchers interested in conducting systematic reviews and meta-analyses. Prospective applicants will play a pivotal role in synthesizing existing evidence to inform decision-making in lung cancer management and improve patient outcomes. The systematic review aims to compile comprehensive evidence to guide clinical practice effectively.
Applicants will conduct systematic reviews and meta-analyses focused on identified review questions (PICOs) using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool. This meticulous process will involve assessing the quality of evidence derived from existing literature and addressing well-defined review questions.
The systematic review and meta-analyses initiative by the ICMR hold promise for revolutionizing lung cancer management in India. By collating and evaluating existing evidence, the initiative aims to fill the critical gap in evidence-based guidelines and enhance clinical practice. Ultimately, this endeavor seeks to improve patient outcomes and mitigate the burden of lung cancer in the country.
In conclusion, the ICMR’s systematic review and meta-analyses initiative represent a proactive step towards addressing the challenges in lung cancer management in India. By leveraging the expertise of researchers and employing robust methodologies, the initiative aims to shape the future of lung cancer care and contribute to better healthcare outcomes for patients across the nation.
